My understanding:
- RC220 delivered H1 2024
- Phase 1a/b commences H2 2024 (12-18 month timeline)
- Phase 2 commence circa H2 2025 / H1 2026 (18-24 month timeline)
I'm sure Dr T is doing everything possible to line up gov / ethic approvals, patient screening for all trials to limit downtime.
FDA approval is "from" Phase 2 data, not completion of the trial so early positive readouts could result in FDA fast track / breakthrough designation before Phase 2 completion?
General Comments / Chat, page-10297
-
- There are more pages in this discussion • 721 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.010(0.59%) |
Mkt cap ! $291.1M | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.75 | $1.70 | $226.9K | 131.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9599 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 4886 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |